文献速递中医内科中药与中成药合理使用

医艾康胶囊治疗艾滋病的随机双盲对照试验

Efficacy and safety of the Chinese herbal medicine Yiaikang capsule in treating AIDS: a randomized, double-blind, controlled trial.
PubMed 文献 · J Ethnopharmacol · 2026-04-10

本研究为随机双盲安慰剂对照多中心试验,纳入144例HIV感染者,评估医艾康胶囊联合抗逆转录病毒治疗48周的疗效与安全性。结果显示联合组CD4计数恢复更优,中医证候改善,免疫激活减轻,未报告严重不良事件。

要点

  • 医艾康胶囊联合ART可促进CD4计数恢复。
  • 联合治疗改善中医证候并降低免疫激活指标。
  • 未报告严重不良事件,安全性良好。

核心结论

  • 医艾康胶囊联合ART可促进CD4计数恢复、改善中医证候并减轻免疫激活。

研究设计与样本

  • 随机、双盲、安慰剂对照、多中心研究,纳入144例HIV感染者,1:1分配接受医艾康胶囊联合ART或安慰剂联合ART,疗程48周。

主要发现

  • 第48周时医艾康组调整后平均CD4计数为488.7 cells/mm3(95%CI 458.2-519.2),安慰剂组为385.9 cells/mm3(95%CI 354.1-417.7),组间差异102.8 cells/mm3(95%CI 59.6-146.0,P<0.001)。
  • 中医证候评分显示联合组在8周后优于安慰剂组(各P<0.001)。
  • 医艾康显著降低CD4+CCR5+、CD4+CXCR4+及白细胞介素-4、干扰素-γ、肿瘤坏死因子-α水平(P<0.05)。
  • 未报告严重不良事件。

临床怎么用

  • 对于HIV感染者,可考虑在ART基础上联合医艾康胶囊以促进免疫恢复和改善中医证候。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: The Shuyu pill is a traditional Chinese medicine (TCM) formula, used to treat Xu Lao for over 1800 years. Studies have reported the effectiveness of Yiaikang capsules (YAK), a modified form of Shuyu pills, in AIDS treatment. However, clinical evidence for the management of AIDS using YAK is lacking. We aimed to evaluate the efficacy and safety of YAK combined with antiretroviral therapy (ART) among people living with HIV infection. MATERIALS AND METHODS: We conducted a randomized, double-blind, placebo-controlled, multicenter study. Patients were assigned 1:1 to receive YAK combined with ART, or placebo combined with ART, for 48 weeks. The primary outcome was changes in CD4 counts. Secondary outcomes were changes in CD4+CCR5+ and CD4+CXCR4+ counts, HIV-1 load, inflammatory markers from the time of screening to week 48, and total TCM score every 4 weeks. RESULTS: We enrolled 144 patients from eight centers. No significant differences were observed in sex, age, CD4 counts, or other baseline characteristics between the two groups. At week 48, the adjusted mean CD4 count reached 488.7 cells/mm3 in the YAK group (95% confidence interval [CI]: 458.2, 519.2), compared with 385.9 cells/mm3 in the placebo group (95% CI: 354.1, 417.7), resulting in a substantial between-group difference of 102.8 cells/mm3 (95% CI: 59.6, 146.0; P < 0.001). TCM syndrome scores indicated that YAK combined with ART was more effective than placebo after 8 weeks (each P < 0.001). YAK significantly reduced the levels of activation markers (CD4+CCR5+, CD4+CXCR4+) and inflammatory cytokines (interleukin-4, interferon-gamma, and tumor necrosis factor-alpha) compared to placebo(P < 0.05). No serious adverse events were reported. CONCLUSIONS: YAK combined with ART promoted CD4 count recovery, improved TCM syndrome, and alleviated immune activation.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Ding X, Meng P, Ma X, et al. Efficacy and safety of the Chinese herbal medicine Yiaikang capsule in treating AIDS: a randomized, double-blind, controlled trial. J Ethnopharmacol. 2026. PMID: 41967778. doi:10.1016/j.jep.2026.121641

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。